Look at the earnings date of Dec 19th . After numbers released, for direction.
All the Good , Bad and Ugly will be on display for the world to see.
If their large salaries are not sufficient to afford lifestyles.? They do not believe there is a large increase in company value coming, thus the continued selling of monthly vested shares. They don't believe their own PR.Action speaks louder than words.
Thank god- I 'm glad this is a non event, was worried about short positions now no longer, hope others take advantage of this mis information and short this to the moon.
Now it help build a large large platform of growth.
IF this Then that. IF is too big of a word. What IF they sell none? I for one would not be happy.
From earnings release to conference call, heard and read nothing on this generic launch status. Maybe it is dead in the water. Price action supports this view. Will see what this management says Wednesday.
When your skilled in the craft? This is one main point in claims construction. To me not skilled in the craft seam completely non equal and ridiculous to compare the two as equal. We will wait and see what the Supreme court says.
Seem like management could buy it out on the cheap after ATLS gets their big buy out payday. Take it private and enjoy cost savings as well.
Bigger failure is lack of FDA approval. No matter patent expires Sept 2015.
Price action seems to confirm. News under Teva